Spelling suggestions: "subject:"pathogenic bacteria"" "subject:"apathogenic bacteria""
1 |
Bacterial cell surfaces and pathogensis : publications 1975-1998 / Paul Alexander Manning.Manning, Paul Alexander. January 1998 (has links)
Includes bibliographical references. / 3 v. var. pagings. : / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Comprises 171 published works on the general theme of bacterial cell surfaces and pathogenesis. Seeks to address important areas facing medical research by the application of bacterial genetics and molecular biology. The common goal is to provide a better understanding of the mechanisms of pathogenesis of the diseases and how these pathogens have evolved such that this information might be applied to vaccine design and diagnosis. / Thesis (D.Sc.)--University of Adelaide, Dept. of Microbiology and Immunology, 2000?
|
2 |
Bacterial cell surfaces and pathogensis : publications 1975-1998 / Paul Alexander Manning.Manning, Paul Alexander. January 1998 (has links)
Includes bibliographical references. / 3 v. var. pagings. : / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Comprises 171 published works on the general theme of bacterial cell surfaces and pathogenesis. Seeks to address important areas facing medical research by the application of bacterial genetics and molecular biology. The common goal is to provide a better understanding of the mechanisms of pathogenesis of the diseases and how these pathogens have evolved such that this information might be applied to vaccine design and diagnosis. / Thesis (D.Sc.)--University of Adelaide, Dept. of Microbiology and Immunology, 2000?
|
3 |
Bacterial cell surfaces and pathogensis : publications 1975-1998 /Manning, Paul Alexander. January 1998 (has links) (PDF)
Thesis (D.Sc.)--University of Adelaide, Dept. of Microbiology and Immunology, 2000? / Includes bibliographical references.
|
4 |
The structure of lipopolysaccharide from Pseudomonas syringae pv. morsprunorum and its role in cherry cankerZamze, S. E. January 1983 (has links)
No description available.
|
5 |
Regulation of the synthesis of extracellular protease and cellulase enzymes in Xanthomonas campestrisHan, Bin January 1992 (has links)
No description available.
|
6 |
Xanthomonas infections of rice : The involvement of bacterial extracellular polysaccharideParry, R. W. H. January 1985 (has links)
No description available.
|
7 |
Factors influencing endospore formation in the genus BacillusPorter, Mary Elizabeth. January 1950 (has links)
Call number: LD2668 .T4 1950 P67 / Master of Science
|
8 |
Chromosomal and plasmid determinants of Rhodococcus equi virulenceHapeshi, Alexia January 2014 (has links)
Rhodococcus equi is a soil-dwelling actinomycete with the ability to cause pyogranulomatous infections in different animal species and people. Young foals are particularly susceptible and develop a severe pulmonary illness known as rhodococcal pneumonia. The infection is endemic in many horse-breeding farms worldwide and poses a major challenge to the equine industry, as there is no commercial vaccine available. R. equi is a facultative intracellular pathogen. Intracellular survival in macrophages and hence virulence depends on the presence of large plasmids that carry a set of genes encoding virulence-associated proteins (Vaps) of largely unknown functions. Virulence plasmids are of different types and appear to determine host-specific infectivity for horses, pigs and cattle. In this thesis, I explored bacterial chromosomal factors that contribute to the virulence of R. equi. Previous microarray transcription profiling work from the laboratory showed that housekeeping metabolic genes from the R. equi chromosome were co-opted to serve a virulence function via co-regulation with plasmid virulence genes. Here, I identified a further virulence plasmid-co-expressed metabolic chromosomal locus with a key role in R. equi pathogenesis. The identified locus, gltAB1, encodes an NADPH-dependent glutamate synthase required for ammonia assimilation under low nitrogen conditions. Reverse-transcription quantitative rea-ltime PCR confirmed that gltAB1 was co-expressed with the vap genes from the plasmid whereas a homologous chromosomal locus encoding a second NADPH-dependent glutamate synthase, gltAB2, was not. In-frame deletion mutants were constructed and their virulence analysed. gltAB1 but not gltAB2, was found to be involved in virulence and required for intracellular proliferation in J774A.1 macrophages. The ΔgltAB1 mutant showed significant attenuation in vivo in a mouse infection model, in contrast to the ΔgltAB2, which behaved like the wild type. The ability of the ΔgltAB1 mutant strain to act as a live attenuated vaccine was tested in experiments in BALB/c mice. The mutant conferred protection against subsequent challenge of the animals with wild-type virulent bacteria, thus identifying a novel candidate vaccine for the control of R. equi pneumonia in foals. Furthermore, this thesis describes studies of the bovine-type plasmid, previously sequenced in our laboratory. The purpose of this work was to determine if VapN, the bovine-type allelic variant of the VapA protein encoded in the equine-type plasmid, was also essential for R. equi virulence. A plasmid-less derivative strain and a deletion mutant in the vapN gene were examined for their ability to proliferate in two different cell lines and to persist in BALB/c mice. These strains showed the same strong virulence attenuation observed with plasmid-less and ΔvapA strains derived from the equine isolate R.equi 103S, demonstrating that the bovine-type VapN protein also plays a central role in R. equi virulence. Additionally, the thesis includes preliminary work on approaches to explore the role and mechanism of Vap proteins in R. equi virulence. It also describes the construction of GFP-tagged R. equi strains for use in cell biological experiments and live imaging of infected cells.
|
9 |
Update and evaluation of 16SpathDB, an automated comprehensive database for identification of medically important bacteria by 16S rRNA gene sequencingYeung, Shiu-yan, 楊兆恩 January 2013 (has links)
Identification of pathogens is one of the important duties of clinical microbiology laboratory. Traditionally, phenotypic tests are used to identify the bacteria. However, due to some limitations of the phenotypic tests, the bacteria may not be identified sometimes and cannot be identified promptly. 16S rRNA gene sequencing is a rapid and accurate method to achieve this target. It is especially useful for identify rare or slow growing bacteria. However, the interpretation of the 16S rRNA gene sequencing result is one of the challenging duties to laboratory technicians and microbiologists. Apart from the well known 16S rRNA gene databases such as Genbank, The Ribosomal Database Project (RDP-II), MicroSeq databases, Ribosomal Differentiation of medical Microorganism database (RIDOM), SmartGene IDNS, 16SpathDB is an automated and comprehensive database for interpret the 16S rRNA gene result. The 16SpathDB first version was established in 2011. In this study, 16SpathDB was updated based on the all clinical important bacteria present in the 10th edition of the Manual of Clinical Microbiology (MCM)(Versalovic. et al., 2011) into this new version of database, 16SpathDB 2.0. The database was evaluated by using 689 16S rRNA gene sequences from 689 complete genomes of medically important bacteria. Among the 689 16S rRNA gene sequences, none was wrongly identified by 16SpathDB 2.0, with 247 (35.8%) 16S rRNA gene sequences reported in only one single bacterial species with more than 98% nucleotide identity with the query sequence (category 1), 440 (63.9%) reported as more than one bacterial species having more than 98% nucleotide identity with the query sequence (category 2), 2 (0.3%) reported to the genus level (category 3), and none reported as “no species in 16SpathDB 2.0 found to be sharing high nucleotide identity to your query sequence” (category 4). 16SpathDB 2.0 is an updated, automated, user-friendly, efficient and accurate database for 16S rRNA gene sequence interpretation in clinical microbiology laboratories. / published_or_final_version / Microbiology / Master / Master of Medical Sciences
|
10 |
Bacteremia due to Elizabethkingia and related speciesFoo, Chuen-hing, 符傳興 January 2014 (has links)
Elizabethkingia spp. is a gram-negative, non-fermenting rod bacterium that is frequently implicated in hospital outbreaks. Elizabethkingia has a high rate of resistance to antibiotics and a shortage of effective parenteral antibiotics usually occurs in intensive care units. Infection includes neonatal sepsis and meningitis. Recently, a new species of Elizabethkingia, which is closely related to E. meningoseptica ATCC 13253 and E. miricola GTC862, was reported as a human pathogen in Central Africa and named E. anophelis. Our investigation involved 27 Elizabethkingia clinical isolates, which were fully identified through phenotypic and genotypic typing. The isolates were identified as E. meningoseptica by VITEK 2 (bioMereux) and Phoneix (Beckton Dickinson) automated bacterial identification systems. We then re-identified the isolates by 16S rRNA gene sequencing; 23 of the 27 strains were identified as E. anophelis and one was identified as E. miricola instead of E. meningoseptica. Subsequently, we evaluated the performance of the Bruker MALDI-TOF MS system for identification of the E. anophelis strains; many were misidentified as E. meningoseptica or were unidentified. All of the strains were correctly re-identified as E. anophelis when the original Bruker database was expanded with the inclusion of 10 E. anophelis clinical isolates and a standard 〖R26 〗^T strain. We also analysed 23 E. anophelis clinical isolates by biochemical tests, antimicrobial susceptibilities tests and pulsed-field gel electrophoresis. From the biochemical investigation of all isolates and type strain, showing that the conventional biochemical tests are not reliable to differentiate E. anophelis from other Elizabethkingia spp. More than 75% of the isolates tested were susceptible to cotrimoxazole, ciprofloxacin, and cefoperazone-sulbactam, however they were all resistant to aminoglycosides and beta-lactam drugs except one strain. At the PFGE investigation all the strains were not clonally related as shown by PFGE and displayed distinct PFGE fingerprints. / published_or_final_version / Medicine / Master / Master of Medical Sciences
|
Page generated in 0.1117 seconds